FDA AdCom Votes in Favor of Emergency Use Authorization for Pfizer (PFE) and BioNTech's (BNTX) Covid-19 Vaccine in Children 5 to <12 Years
Go back to FDA AdCom Votes in Favor of Emergency Use Authorization for Pfizer (PFE) and BioNTech's (BNTX) Covid-19 Vaccine in Children 5 to <12 Years| (NASDAQ: BNTX) | Delayed: 93.80 -0.46 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $94.26 | 52 Week High | $ | |||
| Open | $94.35 | 52 Week Low | $ | |||
| Day High | $95.08 | P/E | N/A | |||
| Day Low | $93.37 | EPS | $ | |||
| Volume | 126,007 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 24.01 -0.36 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.37 | 52 Week High | $37.39 | |||
| Open | $24.43 | 52 Week Low | $28.25 | |||
| Day High | $24.46 | P/E | 14.55 | |||
| Day Low | $23.96 | EPS | $1.65 | |||
| Volume | 11,347,488 | |||||

